You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
复星医药(02196.HK)与豫园股份订立股权和债权转让合同
格隆汇 04-27 07:15

格隆汇 4 月 27日丨复星医药(02196.HK)发布公告,2021年4月26日,公司附属公司禅城医院作为卖方、复星医疗作为卖方及佛山禅曦作为目标公司作为买方与豫园股份作为买方订立转让合同,据此,禅城医院及复星医疗同意以约人民币1.76亿元的总对价向豫园股份转让出售股权,并以约人民币3.739亿元的总对价向豫园股份转让出售债权。

出售事项完成后,豫园股份(或其依约指定的附属公司)将持有佛山禅曦100%的股权,佛山禅曦将不再为公司的附属公司。佛山禅曦系一间于中国成立的有限责任公司,截至本公告日期,由公司附属公司禅城医院及复星医疗分别持有其60%及40%的股权,佛山禅曦系为开展“禅医健康城综合体项目”而设立的公司。

为满足禅城医院发展需要,发挥其在华南地区的医疗优势和辐射示范作用,2018年8月经公司第七届第六十九次董事会审议批准,同意推进建设实施“禅医健康城综合体项目”。由于该项目所涉土地性质为医疗卫生、社会福利混合用地,并相容二类居住用地和商业商务用地,由于该宗土地使用权系整体招拍挂、无法分割,故由专门设立的项目公司(即佛山禅曦)作为土地使用权的摘牌主体,并整体推进该项目实施。

鉴于佛山禅曦“禅医健康城综合体项目”中的商住等部分地产业务与集团主营业务无关,但禅城医院与佛山禅曦已就该项目用于运营妇女儿童医学中心、养护院的相关物业已签订定制协议,约定于定制工程完成竣工验收备案后及时交付禅城医院使用,并以资产转让的方式将定制工程的产权办理至禅城医院名下。因此,为聚焦主业,集团拟对佛山禅曦股权进行整体转让。

订立转让合同为满足禅城医院重点扩容和发展妇女儿童医学中心、养护院提供医疗场地保障,进一步发挥其专业特色和优势,满足大湾区不断增加的高端医疗需求的同时,也有利于集团聚焦主业。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account